These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF. Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409 [TBL] [Abstract][Full Text] [Related]
5. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy. Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497 [TBL] [Abstract][Full Text] [Related]
6. Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells. Casaroli-Marano RP; Pagan R; Vilaró S Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2062-72. PubMed ID: 10440262 [TBL] [Abstract][Full Text] [Related]
7. Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy. Lashkari K; Rahimi N; Kazlauskas A Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):149-56. PubMed ID: 9888438 [TBL] [Abstract][Full Text] [Related]
8. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
9. Expression and upregulation of microtubule-associated protein 1B in cultured retinal pigment epithelial cells. Esser P; Grisanti S; Kociok N; Abts H; Hueber A; Unfried K; Heimann K; Weller M Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2852-6. PubMed ID: 9418739 [TBL] [Abstract][Full Text] [Related]
10. EIU in the rat promotes the potential of syngeneic retinal cells injected into the vitreous cavity to induce PVR. Behar-Cohen FF; Thillaye-Goldenberg B; de Bizemont T; Savoldelli M; Chauvaud D; de Kozak Y Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3915-24. PubMed ID: 11053294 [TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemical study on vitrectomy specimens of proliferative retinal diseases]. Cao J; Wu L; Zhang H Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):264-7. PubMed ID: 10451957 [TBL] [Abstract][Full Text] [Related]
12. The properties of retinal pigment epithelial cells in proliferative vitreoretinopathy compared with cultured retinal pigment epithelial cells. Abe T; Durlu YK; Tamai M Exp Eye Res; 1996 Aug; 63(2):201-10. PubMed ID: 8983978 [TBL] [Abstract][Full Text] [Related]
13. Vitreous modulation of gene expression in low-passage human retinal pigment epithelial cells. Ganti R; Hunt RC; Parapuram SK; Hunt DM Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1853-63. PubMed ID: 17389521 [TBL] [Abstract][Full Text] [Related]
14. Ultrastructural and immunocytochemical changes in retinal pigment epithelium, retinal glia, and fibroblasts in vitreous culture. Vinores SA; Campochiaro PA; McGehee R; Orman W; Hackett SF; Hjelmeland LM Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2529-45. PubMed ID: 1702409 [TBL] [Abstract][Full Text] [Related]